4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-004833
Chief Accounting Officer sold 332 shares at $0.44 ($146)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-10 | Sale : show line 1 in the form | −332 | $0.44 | $146 | 68,174 | D |
| Open-market sales · 332 sh · avg $0.44 · $146 | ||||||
Loading xslF345X05/ownership.xml…